Skip to main content
. Author manuscript; available in PMC: 2014 Oct 17.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Feb 25;20(5):1039–1042. doi: 10.1158/1055-9965.EPI-11-0135

Table 1. Association of known T2D and obesity risk alleles with breast cancer risk by race/ethnicity.

OR(95%CI)a
Risk allele frequency in controls
SNP/
Allele
testedb
Chr./
Nearest gene
European
Americans
503 cases
633 controls
African
Americans
381 cases
542 controls
Native
Hawaiians
135 cases
344 controls
Japanese
Americans
509 cases
782 controls
Latinos
355 cases
505 controls
Pooled
1,883 cases
2,806 controls
P for
trend
pooled
Phetc
Type 2 Diabetes SNPs
rs10923931
T
1
NOTCH2
1.13(0.85-1.49)
0.097
0.87(0.71-1.07)
0.33
0.96(0.49-1.86)
0.055
0.97(0.58-1.63)
0.025
1.28(0.93-1.76)
0.095
1.01(0.88-1.15)
0.12
0.94 0.32
rs7578597
T
2
THADA
1.05(0.88-1.48)
0.89
1.13(0.90-1.41)
0.75
1.04(0.54-2.00)
0.95
1.47(0.69-3.15)
0.99
0.71(0.48-1.03)
0.94
1.03(0.89-1.20)
0.90
0.69 0.27
rs1801282
C
3
PPARG
1.14(0.88-1.48)
0.87
0.70(0.39-1.26)
0.98
1.06(0.55-2.04)
0.94
0.83(0.54-1.28)
0.97
1.15(0.84-1.57)
0.89
1.04(0.88-1.23)
0.93
0.63 0.41
rs4607103
C
3
ADAMTS9
0.86(0.71-1.04)
0.74
0.99(0.81-1.22)
0.71
0.89(0.64-1.22)
0.74
0.95(0.80-1.13)
0.65
0.99(0.80-1.22)
0.68
0.94(0.86-1.03)
0.70
0.20 0.81
rs4402960
T
3
IGF2BP2
0.91(0.76-1.08)
0.34
1.07(0.88-1.30)
0.49
0.89(0.64-1.23)
0.28
0.91(0.76-1.08)
0.33
1.16(0.92-1.45)
0.26
0.98(0.89-1.07)
0.34
0.61 0.30
rs10010131
G
4
WFS1
1.01(0.86-1.20)
0.59
0.91(0.74-1.12)
0.67
0.86(0.60-1.23)
0.80
1.14(0.68-1.89)
0.98
0.96(0.78-1.19)
0.70
0.97(0.87-1.07)
0.76
0.55 0.82
rs7754840
C
6
CDKAL1
1.02(0.85-1.20)
0.31
1.10(0.91-1.34)
0.54
1.04(0.78-1.38)
0.52
1.06(0.90-1.25)
0.43
1.00(0.81-1.23)
0.32
1.05(0.96-1.14)
0.42
0.29 0.97
rs864745
A
7
JAZF1
0.93(0.78-1.09)
0.53
0.87(0.71-1.07)
0.74
0.81(0.59-1.10)
0.72
1.02(0.84-1.23)
0.78
1.01(0.83-1.24)
0.62
0.94(0.86-1.03)
0.68
0.17 0.68
rs13266634
C
8
SLC30A8
1.00(0.83-1.20)
0.71
0.78(0.57-1.07)
0.90
0.95(0.70-1.28)
0.63
1.05(0.89-1.24)
0.63
1.04(0.82-1.31)
0.75
1.00(0.90-1.10)
0.72
0.91 0.60
rs2383208
A
9
CDKN2B
1.01(0.81-1.25)
0.81
1.06(0.83-1.34)
0.80
0.98(0.71-1.35)
0.74
1.07(0.91-1.26)
0.57
0.96(0.73-1.27)
0.86
1.03(0.93-1.13)
0.74
0.62 0.92
rs1111875
G
10
HHEX
1.01(0.85-1.20)
0.60
1.16(0.93-1.46)
0.75
1.09(0.79-1.52)
0.30
1.20(1.00-1.44)
0.26
0.94(0.76-1.16)
0.63
1.07(0.98-1.18)
0.50
0.15 0.48
rs7903146
T
10
TCF7L2
1.06(0.89-1.28)
0.29
1.00(0.81-1.23)
0.27
1.16(0.77-1.73)
0.14
1.05(0.72-1.55)
0.045
1.00(0.79-1.27)
0.22
1.03(0.92-1.15)
0.19
0.59 0.98
rs12779790
C
10
CDC123
0.88(0.71-1.10)
0.17
0.97(0.74-1.26)
0.14
1.15(0.80-1.64)
0.18
1.21(0.97-1.49)
0.16
0.98(0.76-1.27)
0.17
1.03(0.92-1.15)
0.16
0.63 0.33
rs2237895d
C
11
KCNQ1
0.99(0.83-1.18)
0.42
0.98(0.77-1.25)
0.21
0.94(0.68-1.31)
0.36
1.06(0.88-1.32)
0.35
1.00(0.80-1.27)
0.42
1.00(0.90-1.10)
0.35
0.93 0.96
rs2237897d
C
11
KCNQ1
1.01(0.68-1.49)
0.95
1.13(0.80-1.59)
0.92
1.13(0.77-1.67)
0.78
0.92(0.75-1.13)
0.62
0.97(0.74-1.26)
0.78
1.00(0.89-1.13)
0.80
1.00 0.016
rs5219
T
11
KCNJ11
1.07(0.90-1.28)
0.35
0.77(0.55-1.08)
0.10
1.01(0.75-1.37)
0.38
0.81(0.68-0.95)
0.39
0.77(0.63-0.96)
0.39
0.89(0.81-0.97)
0.32
0.012 0.082
rs7961581
C
12
TSPAN8
0.96(0.79-1.17)
0.27
0.95(0.75-1.20)
0.21
1.10(0.80-1.51)
0.28
1.01(0.82-1.24)
0.20
1.27(1.00-1.60)
0.20
0.94(0.76-1.15)
0.23
0.60 0.39
rs8050136
A
16
FTO
0.86(0.72-1.02)
0.42
0.89(0.73-1.08)
0.44
0.63(0.43-0.93)
0.24
1.07(0.88-1.30)
0.21
0.96(0.77-1.19)
0.28
0.91(0.83-1.00)
0.32
0.055 0.21
Obesity SNPs
rs2815752
A
1
NEGR1
1.00(0.85-1.19)
0.63
1.10(0.90-1.34)
0.54
1.04(0.70-1.56)
0.83
0.85(0.64-1.14)
0.93
1.06(0.85-1.31)
0.71
1.02(0.92-1.13)
0.73
0.70 0.63
rs10913469
C
1
SEC16B
0.99(0.80-1.23)
0.18
0.87(0.70-1.08)
0.28
0.57(0.38-0.85)
0.21
1.20(1.00-1.44)
0.23
0.89(0.70-1.14)
0.20
0.96(0.86-1.06)
0.22
0.38 0.016
rs6548238
T
2
TMEM18
1.08(0.87-1.34)
0.17
1.07(0.80-1.44)
0.11
0.59(0.31-1.13)
0.079
1.15(0.89-1.49)
0.10
1.17(0.88-1.56)
0.13
1.08(0.95-1.22)
0.12
0.23 0.40
rs10938397
G
4
GNPDA2
0.93(0.78-1.10)
0.42
0.81(0.64-1.02)
0.25
1.14(0.83-1.55)
0.28
0.97(0.81-1.16)
0.29
1.08(0.88-1.32)
0.35
0.97(0.89-1.06)
0.32
0.50 0.34
rs925946e
T
11
BDNF
0.92(0.76-1.12)
0.29
1.01(0.81-1.26)
0.28
1.73(1.19-2.53)
0.18
1.12(0.70-1.77)
0.030
0.90(0.70-1.15)
0.23
1.02(0.91-1.14)
0.19
0.78 0.24
rs6265e
C
11
BDNF
1.33(1.06-1.68)
0.79
1.32(0.85-2.05)
0.94
0.70(0.51-0.97)
0.68
0.92(0.78-1.09)
0.60
0.91(0.70-1.19)
0.85
1.01(0.91-1.12)
0.76
0.88 0.049
rs10838738
G
11
MTCH2
0.99(0.83-1.19)
0.34
1.16(0.86-1.56)
0.11
0.96(0.70-1.33)
0.32
0.99(0.83-1.17)
0.34
1.17(0.96-1.43)
0.35
1.05(0.95-1.15)
0.29
0.36 0.58
rs7138803
A
12
BCDIN3D
0.93(0.78-1.10)
0.39
0.97(0.77-1.23)
0.19
0.97(0.68-1.38)
0.19
1.06(0.90-1.26)
0.34
0.97(0.78-1.21)
0.26
0.99(0.90-1.09)
0.29
0.83 0.90
rs7498665
G
16
SH2B1
0.82(0.69-0.97)
0.40
1.03(0.84-1.26)
0.27
1.03(0.75-1.41)
0.28
1.00(0.79-1.27)
0.13
0.87(0.72-1.06)
0.45
0.92(0.83-1.01)
0.30
0.073 0.47
rs8050136
A
16
FTO
0.87(0.74-1.03)
0.42
0.91(0.75-1.10)
0.44
0.60(0.41-0.86)
0.24
1.04(0.86-1.26)
0.21
0.96(0.78-1.19)
0.28
0.92(0.84-1.00)
0.32
0.055 0.21
rs17782313
C
18
MC4R
0.97(0.80-1.19)
0.22
0.98(0.80-1.20)
0.29
1.00(0.65-1.52)
0.13
0.95(0.79-1.15)
0.23
0.92(0.68-1.23)
0.13
0.98(0.88-1.08)
0.21
0.63 0.98
rs11084753
G
19
KCTD15
0.89(0.75-1.07)
0.68
1.12(0.92-1.36)
0.64
1.04(0.78-1.39)
0.42
1.03(0.87-1.22)
0.29
0.96(0.79-1.18)
0.67
1.00(0.91-1.09)
0.53
0.97 0.53
rs29941
G
19
KCTD15
0.90(0.75-1.08)
0.69
1.11(0.86-1.42)
0.82
0.87(0.65-1.17)
0.40
1.05(0.87-1.27)
0.21
0.81(0.66-1.00)
0.66
0.94(0.85-1.03)
0.54
0.18 0.26
a

OR adjusted for age(quartiles), BMI(quartiles), diabetes status (self-report) and ethnicity (in pooled analysis).

b

NCBI build 36 (forward strand).

c

P value for heterogeneity between risk allele and ethnic groups (4-df).

d

Rs2237895 and rs2237897 adjusted for each other.

e

Rs925946 and rs6265 adjusted for each other.